ArticlePDF Available

Abstract

Chnoospora minima is a brown alga enriched with unique bioactive compounds which are ideal candidates for pharmaceutical, cosmeceutical and nutraceutical industries. During this study, C. minima was extracted using 80% methanol and de-polysaccharide crude methanol extract was obtained by ethanol precipitation followed by separation of the polysaccharide portion. The crude methanol extract of C. minima and its fractions were subjected to analyse phytochemicals and antioxidant activities. For the assessment of radical scavenging activity, DPPH, FRAP, ABTS+, and ORAC assays were conducted. Ethyl acetate fractions of both polysaccharide (IC50:0.67 ± 0.01 mg/mL) and de�polysaccharide (IC50:0.59 ± 0.015 mg/mL) crude methanol extracts exhibited DPPH radical scavenging activity in terms of antioxidant activity. Similarly, the highest level of ORAC, FRAP, and ABTS+ activity was observed in the ethyl acetate fractions of de-polysaccharide (ORAC:19.73 ± 5.31 mg TE/g; FRAP: 20.34 ± 1.72 mg TE/g; ABTS+: 0.06 ± 0001 IC50(mg/ml)) and polysaccharide crude methanol extracts (ORAC:16.22 ± 4.31 mg TE/g; FRAP: 19.23 ± 1.98 mg TE/g; ABTS+:0.08 ± 0.002 IC50(mg/ml)). High TPC was observed in the depolysaccharide crude methanol extract (298.07 ± 0.003 mg GAE/g) and aqueous fraction (141.2 ± 0.002 mg GAE/g) of the polysaccharide crude methanol extract. Highest TFC was observed in both aqueous fractions of depolysaccharide (594.23 ± 0.001 mg QE/g) and polysaccharide (113.46 ± 0.001 mg QE/g) crude methanol extracts. Chloroform fractions exhibited the highest TAC for polysaccharide (2.20 ± 0.45 mg PE/g), and depolysaccharide (2.79 ± 0.31 mg PE/g) samples. Therefore, the depolysaccharide C. minima sample exhibited high level of antioxidant activity along with a high content of phytochemicals which can further be utilized to determine bioactivities that lead to future drug development.
! !!!!!!!!!! !
!
69!
!
Comparison!of!Phytochemicals!and!Antioxidant!Activity!of!the!
Polysaccharide!and!de-polysaccharide!Methanol!Extracts!of!Brown!
Seaweed!Chnoospora!minima!
HS!Kumarasinghe&1,3,!TL!Gunathilaka2,!PT!Jayasooriya3,!P!Ranasinghe4,!LDC!Peiris5,!and!KW!
Samarakoon1,&#&
&
1C)82"2B2$%5+,%&+?K")(2+,"(*%PD7()#$D%G$8$(,#'%()D%LDB#(2"+)%W146:&PGLX-%.$)$,(*%/",%0+')%
1+2$*(3(*(%4$5$)#$%6)"7$,8"29-%G(2?(*()(-%/,"%<()=("
!24$J(,2?$)2%+5%P#BJB)#2B,$-%>(#B*29%+5%H$(*2'%/#"$)#$8-%1((28B%C)2$,)(2"+)(*%6)"7$,8"29-%N(22(,(?B**(-%
/,"%<()=(%
34$J(,2?$)2%+5%N"+J,+#$88%O$#')+*+M9-%>(#B*29%+5%O$#')+*+M9-%G(A(,(2(%6)"7$,8"29%+5%/,"%<()=(-%
;"'")2(*$-%/,"%<()=(%
4C)DB82,"(*%O$#')+*+M9%C)82"2B2$-%H(*K(,(3(%.(,D$)8-%;(*(K$%ETEEF-%/,"%<()=(%
54$J(,2?$)2%+5%t++*+M9%`%.$)$2"#8%@%;+*$#B*(,%N"+*+M9%6)"2-%>(#B*29%+5%PJJ*"$D%/#"$)#$8%W&$)2$,%5+,%
N"+2$#')+*+M9X-%6)"7$,8"29%+5%/,"%0(9$3(,D$)$JB,(-%QBM$M+D(%ET^FT-%/,"%<()=(%
!!"#"$"%&&'%(%)*+",+-%.
Abstract:&&')++8J+,(% ?")"?(% "8% (% K,+3)% (*M(%
$),"#'$D%3"2'%B)"\B$%K"+(#2"7$%#+?J+B)D8%3'"#'%
(,$% "D$(*% #()D"D(2$8% 5+,% J'(,?(#$B2"#(*-%
#+8?$#$B2"#(*% ()D% )B2,(#$B2"#(*% ")DB82,"$8V%
4B,")M%2'"8%82BD9-%&V%?")"?(%3(8%$Z2,(#2$D%B8")M%
_Tr% ?$2'()+*% ()D% D$:J+*98(##'(,"D$% #,BD$%
?$2'()+*% $Z2,(#2% 3(8% +K2(")$D% K9% $2'()+*%
J,$#"J"2(2"+)% 5+**+3$D% K9% 8$J(,(2"+)% +5% 2'$%
J+*98(##'(,"D$% J+,2"+)V% O'$% #,BD$% ?$2'()+*%
$Z2,(#2% +5% &V% ?")"?(% ()D% "28% 5,(#2"+)8% 3$,$%
8BKA$#2$D% 2+% ()(*98$% J'92+#'$?"#(*8% ()D%
()2"+Z"D()2%(#2"7"2"$8V%
>+,%2'$%(88$88?$)2%+5%,(D"#(*%8#(7$)M")M%(#2"7"29-%
4IIH-% >GPI-% PNO/+,% ()D% bGP&% (88(98% 3$,$%
#+)DB#2$DV% L2'9*% (#$2(2$% 5,(#2"+)8% +5% K+2'%
J+*98(##'(,"D$%WC&50dTVfe%i%TVTE%?M`?<X%()D%D$:
J+*98(##'(,"D$%WC&50dTVFY% i% TVTEF%?M`?<X%#,BD$%
?$2'()+*% $Z2,(#28% $Z'"K"2$D% 4IIH% ,(D"#(*%
8#(7$)M")M% (#2"7"29% ")% 2$,?8% +5% ()2"+Z"D()2%
(#2"7"29V%/"?"*(,*9-%2'$%'"M'$82%*$7$*%+5%bGP&-%>GPI-%
()D% PNO/u% (#2"7"29% 3(8% +K8$,7$D% ")% 2'$% $2'9*%
(#$2(2$% 5,(#2"+)8% +5% D$:J+*98(##'(,"D$%
WbGP&dEYVeU%i%FVUE%?M%OL`Mg%>GPId%^TVUj%i%EVe^%
?M%OL`Mg%PNO/ud%TVTf%i%TTTE%C&FTW?M`?*XX%()D%
J+*98(##'(,"D$% #,BD$% ?$2'()+*% $Z2,(#28%
WbGP&dEfV^^%i%jVUE%?M%OL`Mg%>GPId%EYV^U%i%EVY_%
?M%OL`Mg%PNO/+dTVT_%i%TVTT^%C&FTW?M`?*XXV%H"M'%
OI&%3(8% +K8$,7$D%")%2'$%D$J+*98(##'(,"D$%#,BD$%
?$2'()+*%$Z2,(#2%W^Y_VTe%i%TVTTU%?M%.PL`MX%()D%
(\B$+B8%5,(#2"+)%WEjEV^%i%TVTT^%?M%.PL`MX%+5%2'$%
J+*98(##'(,"D$% #,BD$% ?$2'()+*% $Z2,(#2V% H"M'$82%
O>&% 3(8% +K8$,7$D% ")% K+2'% (\B$+B8% 5,(#2"+)8% +5%
D$J+*98(##'(,"D$%WFYjV^U%i%TVTTE%?M% ]L`MX%()D%
J+*98(##'(,"D$%WEEUVjf% i%TVTTE%?M% ]L`MX% #,BD$%
?$2'()+*%$Z2,(#28V%&'*+,+5+,?%5,(#2"+)8%$Z'"K"2$D%
2'$% '"M'$82% OP&% 5+,% J+*98(##'(,"D$% W^V^T% i% TVjF%
?M%IL`MX-%()D%D$J+*98(##'(,"D$%W^VeY%i%TVUE%?M%
IL`MX%8(?J*$8V%O'$,$5+,$-%2'$%D$J+*98(##'(,"D$%&V%
?")"?(%8(?J*$%$Z'"K"2$D%'"M'%*$7$*%+5%()2"+Z"D()2%
(#2"7"29% (*+)M% 3"2'% (% '"M'% #+)2$)2% +5%
J'92+#'$?"#(*8% 3'"#'%#()% 5B,2'$,% K$% B2"*"[$D% 2+%
D$2$,?")$% K"+(#2"7"2"$8% 2'(2% *$(D% 2+% 5B2B,$% D,BM%
D$7$*+J?$)2V%%
!
! !!!!!!!!!! !
!
70!
Keywords:! &')++8J+,(& B-$-B'C& ("7
JDEM/'%%H'+-("& "_*+'%*0& JDEM/'%%H'+-("& "_*+'%*0&
G$*-D_-('$*&'%*-K-*MC&UHM*D%H"B-%'E/&
&
1. Introduction%
='+-$"& [-D*"%H$DED,M& -/& '& [+D'(& #-"E(& @H"+"&
("B'$(& #D+& $"@& +"/"'+%H& '$(& ("K"EDJB"$*&
*"%H$-b."/& -/& +-/"& .J& ('M& [M& ('M^& ZH"$&
%D$/-("+-$,& JH'+B'%".*-%'EC& $.*+'%".*-%'EC& '$(&
%D/B"%".*-%'E& -$(./*+-"/C& B'+-$"& [-D+"/D.+%"/&
-$%E.(-$,& B'%+D& '$(& B-%+D'E,'"C& %+./*'%"'$/C&
B'+-$"&B'BB'E/&'$(&/"'@""(/&JE'M&'&K-*'E&+DE"&
-$& -*& XZ'$7?DM&'$(& )-"@7=D-C& 9<A8Y& XLD++"/& "*&
'E^C&9<A4Y^&&
)+-& ?'$T'& -/& '& *+DJ-%'E& %D.$*+M& ED%'*"(& -$& *H"&
1$(-'$&D%"'$&$"'+&*D&*H"&"b.'*D+&@-*H&'[D.*&94#&
D#&'K"+',"&*"BJ"+'*.+"&-$&-*/&%D'/*'E&'+"'/^&!."&
*D&*H-/&#'KD.+'[E"&%E-B'*"&%D$(-*-D$/&'K'-E'[E"&-$&
*H"&%D'/*'E&'+"'/C&-*&J+DK-("&*H"&H'[-*'*&#D+&ED*/&D#&
B'+-$"&[-D/D.+%"/&-$%E.(-$,&'E,'"&'$(&'%*/&'/&'&
H.[&#D+&(-##"+"$*&B'+-$"&JE'$*&K'+-"*-"/&*D&,+D@&
X\"+$'$(DC& 9<A5Y^& GBD$,& *HD/"& B'+-$"&
[-D+"/D.+%"/C&B'+-$"&'E,'"&'+"&-("'E&%'$(-('*"/&
@-*H& K'/*& K'+-"*M& D#& [-DED,-%'EEM& '%*-K"&
%DBJD.$(/& -$%E.(-$,& *"+J"$D-(/C& 'ET'ED-(/C&
JDEMJH"$DE/C& /.EJH'*"(& JDEM/'%%H'+-("/C&
J"J*-("/C&'B-$D&'%-(/C&H'ED,"$'*"(&%DBJD.$(/&
'$(& JDEM.$/'*.+'*"(& #'**M& '%-(/& *H'*& '+"&
+"/JD$/-[E"& #D+& '$*-D_-('$*C& '$*-7%'$%"+C& '$*-7
(-'["*-%C& '$*-7@+-$TE"C& '$*-7',-$,C& '$*-7
-$#E'BB'*D+MC& '$*-7D["/-*M& '$(& '$*-7['%*"+-'E&
'%*-K-*-"/& X!M/HEDKDM& '$(& FD$"%T"+C& 9<A;Y&
X!D[+"*/DK&"*&'E^C&9<A8Y^&1$&,"$"+'EC&'E,'"&%'$&["&
%E'//-#-"(& -$& *D& *H+""& B'-$& /",B"$*/& '/&
+HD(DJHM*'C&%HED+DJHM*'C&'$(&JH'"DJHM*'&['/"(&
D$&*H"-+&%DED.+& @H-%H& -/& D%%.++"(& '/& '& +"/.E*& D#&
*H"& 'K'-E'[-E-*M& D#& JHD*D/M$*H"*-%& J-,B"$*/&
X‹'T-+&G+-%'&"*&'E^C&9<A5Y&XG[-+'B-&'$(&VD@/'EM'C&
9<A8Y^& h.*& D#& *H"/"& -BJD+*'$*& B'+-$"& 'E,'"C&
IH$DD/JD+'&B-$-B'&-/&'&B'+-$"&'E,'&*H'*&%'$&["&
#D.$(& $"'+& *H"& %D'/*'E& '+"'/& D#& ='$$'+C&
F-TT'(.@'C&Q'EE"C&'$(&3-E'K"E-&-$&)+-&?'$T'^&
&
=D/*& %DBBD$EMC& ("*"%*-D$& D#& JHM*D%H"B-%'E/&
+"J+"/"$*/& *H"& [-D'K'-E'[-E-*M& D#& JDEMJH"$DE/C&
#E'KD$D-(/&'$(&'ET'ED-(/&@-*H-$&$'*.+'E&"_*+'%*/&
@H-%H& '+"& "$%D.$*"+"(& #D+& (-##"+"$*& B"(-%-$'E&
J+DJ"+*-"/& -$%E.(-$,& '$*-7%'$%"+C& '$*-(-'["*-%C&
'$*-7-$#E'BB'*D+M& '$(&'$*-7['%*"+-'E& "*%& X‹'T-+&
G+-%'& "*& 'E^C& 9<A5Y^& )-B-E'+EMC& -$K"/*-,'*-D$& D#&
'$*-7D_-('$*& '%*-K-*-"/& %"$*"+"(& @-*H& *H"&
#D+B.E'*-D$&D#&$DK"E&#DD(&'$(&(+.,/&'/&*H"M&'+"&
*D*'EEM&("'E&@-*H&*H"&H.B'$&H"'E*H&'$(&@"EE["-$,&
*D& B-*-,'*"& (-##"+"$*& (-/"'/"/& D+& *D& %D.$*"+'%*&
D_-('*-K"& /*+"//& XK'$& Z""E("$& "*& 'E^C& 9<A4Y&
XQ.*-Œ++"]7PD(+‡,."]&"*&'E^C&9<A6Y^&GE*"+$'*-K"EMC&
*H"/"& '$*-D_-('$*/&%'$& "E-B-$'*"& D+& '+"& '[E"& *D&
+"(.%"& E-J-(& J"+D_-('*-D$& @H-%H& -$& *.+$&
+"/JD$/-[E"&#D+&*H"&J+DED$,-$,&D#&#DD(&'$(&(+.,&
/H"E#&E-K"/^&1$&'((-*-D$&*D&*H'*C&*H"/"&'$*-D_-('$*&
'%*-K-*-"/& '+"& -("'E& #D+& /T-$& *+"'*B"$*/& '/& @"EE&
XK'$&Z""E("$&"*&'E^C&9<A4Y&XQ'$"/'$C&V.B'+&'$(&
2H'/T'+C&9<<6Y^&
&
1$& *H-/& -$K"/*-,'*-D$C& -*& -$*"$("(& *D& "_JED+"C&
%DBJ'+"& '$(& %D$*+'/*& *H"& JHM*D%H"B-%'E&
%DBJD/-*-D$& '$(& '$*-D_-('$*& '%*-K-*-"/& D#&
JDEM/'%%H'+-("& '$(& ("7JDEM/'%%H'+-("& /'BJE"/&
'$(& #+'%*-D$/& D#& )+-& ?'$T'$& B'+-$"& 'E,'&
IH$DD/JD+'& B-$-B'C& '$(& *D& -$K"/*-,'*"& ["/*&
/'BJE"& D.*& D#& *H"B& -$& D+("+& *D& "_'B-$"& *H"-+&
JD*"$*& -$%D+JD+'*-D$& -$& JH'+B'%".*-%'EC&
%D/B"%".*-%'E& '$(& $.*+'%".*-%'E& -$(./*+M&
'JJE-%'*-D$/^&
2.%%Methodology%
AY&)'BJE"&J+"J'+'*-D$&
A^AY& UDEM/'%%H'+-("& +-%H& B"*H'$DE& "_*+'%*0&
U+"K-D./EM&%DEE"%*"(&'$(&#+""]"7(+-"(&I^&B-$-B'&
'E,'& /'BJE"/& @"+"& *'T"$& '$(& #-$"EM& JD@("+"(&
./-$,& B"%H'$-%'E& ,+-$("+^& LH"$& 9<<,& D#&
JD@("+"(&I^&B-$-B'&/'BJE"/&@"+"&"_*+'%*"(&*D&
6<g&B"*H'$DE&X;?Y&./-$,&/D$-%'*-D$&B"*HD(&#D+&
4<&B-$.*"/&'*&9;&kI&XO&*-B"/Y^&="*H'$DE&"_*+'%*/&
D#&I^&B-$-B'&@"+"&*H"$& #-E*"+"(&#D+& *H+""& *-B"/&
./-$,& %"-E-*"& ["(& J'%T"(& -$& '& /-$*"+& #.$$"E& '$(&
%D$%"$*+'*"(& [M& ./-$,& '& +D*'+M& "K'JD+'*D+& '*&
! !!!!!!!!!! !
!
71!
:6& kI^& ID$%"$*+'*"(& JDEM/'%%H'+-("& %+.("&
B"*H'$DE& "_*+'%*&D#& I^& B-$-B'& @'/& *H"$& #+""]"&
(+-"(&*D&D[*'-$&/DE-(&%+.("&B"*H'$DE&"_*+'%*&*D&
+"BDK"& 'EE& @'*"+& '$(& D[*'-$"(& /DE-(& %+.("&
B"*H'$DE& "_*+'%*& @'/& /*D+"(& '*& 79<& kI& .$*-E&
#.+*H"+& ./"^& h[*'-$"(& /DE-(& %+.("& B"*H'$DE&
"_*+'%*& @"+"& (-//DEK"(& -$& !=)h& *D& J+"J'+"&
T$D@$& /*D%T& /'BJE"& %D$%"$*+'*-D$/^& XA<,lBEY&
XQ.$'*H-E'T'&"*&'E^C&9<A4Y^&&
&
A^9Y&!"7JDEM/'%%H'+-("&%+.("& B"*H'$DE&"_*+'%*0&
U+"K-D./EM& %DEE"%*"(C& #+""]"& (+-"(& I^& B-$-B'&
'E,'"&/'BJE"/&@"+"& *'T"$&'$(& #-$"EM& JD@("+"(&
./-$,&B"%H'$-%'E& ,+-$("+^&9<<,&D#& JD@("+"(&I^&
B-$-B'& /'BJE"/& @"+"& "_*+'%*"(& *D& 6<g&
B"*H'$DE& X;?Y& ./-$,& /D$-%'*-D$& B"*HD(& #D+& 4<&
B-$.*"/&'*&9;&kI&XO&*-B"/Y^&="*H'$DE&"_*+'%*/&D#&
I^& B-$-B'& @"+"& *H"$& #-E*"+"(& #D+& *H+""& *-B"/&
./-$,& %"-E-*"& ["(& J'%T"(& -$& '& /-$*"+& #.$$"E& '$(&
%D$%"$*+'*"(& [M& ./-$,& '& +D*'+M& "K'JD+'*D+& '*&
:6&kI^&JDEM/'%%H'+-("&%+.("&B"*H'$DE&"_*+'%*&D#&
I^& B-$-B'X%D$%"$*+'*"(Y& @'/& J+"%-J-*'*"(&
DK"+$-,H*& @-*H& "*H'$DE& *D& +"BDK"& 'EE& *H"&
JDEM/'%%H'+-("/^& LH"+"'#*"+C& *D& +"BDK"& *H"&
"*H'$DE& %D$*"$*C& /'BJE"/& @"+"& /.[S"%*"(& *D&
%D$%"$*+'*-D$& K-'& +D*'+M& "K'JD+'*D+^&
ID$%"$*+'*"(& ("7JDEM/'%%H'+-("& I^& B-$-B'&
%+.("&B"*H'$DE&"_*+'%*&@'/&*H"$&#+""]"&(+-"(&*D&
D[*'-$& /DE-(& %+.("& B"*H'$DE& "_*+'%*& '$(&
D[*'-$"(& /DE-(& %+.("& B"*H'$DE& "_*+'%*& @'/&
/*D+"(&'*&79<&kI&.$*-E&#.+*H"+&./"^&h[*'-$"(&/DE-(&
%+.("& B"*H'$DE& "_*+'%*/& @"+"& (-//DEK"(& -$&
!=)h& *D& J+"J'+"& T$D@$& /*D%T& /'BJE"&
%D$%"$*+'*-D$/^& XA<,lBEY& XQ.$'*H-E'T'& "*& 'E^C&
9<A4Y^&&
9Y&)DEK"$*&#+'%*-D$&J+"J'+'*-D$&
9;<B,&D#&[D*H&JD@("+"(&JDEM/'%%H'+-("&'$(&("7
JDEM/'%%H'+-("& %+.("& B"*H'$DE& "_*+'%*/& @"+"&
(-//DEK"(& -$& A<<& BE& D#& ("-D$-]"(& @'*"+&
/"J'+'*"EM& '$(& J'+*-*-D$"(^& U'+*-*-D$-$,& @'/&
(D$"&./-$,&A<<BE&H"_'$"C&%HED+D#D+B&'$(&"*HME&
'%"*'*"&+"/J"%*-K"EM&'%%D+(-$,&*D&*H"&'/%"$(-$,&
D+("+& D#& *H"-+& JDE'+-*M& XA<<& BE& u& O& *-B"/Y& *D&
D[*'-$& #D.+& #+'%*-D$/& #+DB& /'BJE"/& '/& F"_'$"C&
%HED+D#D+BC&"*HME&'%"*'*"&'$(&'b."D./&#+'%*-D$/^&
G#*"+&*H"&J'+*-*-D$-$,&J+D%"//C&'EE&#+'%*-D$/&@"+"&
"K'JD+'*"(& #D+& DK"+$-,H*& *D& +"BDK"& 'EE& *H"&
/DEK"$*/&X'-+&(+MY^&GEE&(+-"(&#+'%*-D$/&@"+"&/*D+"(&
'*& 79<& kI& .$*-E& ./"^& \-$'EEMC& 'EE& #+'%*-D$/& @"+"&
(-//DEK"(& -$& !=)h& *D& B'T"& T$D@$&
%D$%"$*+'*-D$/&D#&/*D%T&/'BJE"/^&XA<B,lBEY^&
&
OY&1$&K-*+D&JHM*D%H"B-%'E&'//'M/&
O^AY& LD*'E& JDEMJH"$DE-%& %D$*"$*& XLUIY&
("*"+B-$'*-D$0& LD*'E& JDEMJH"$DE-%& %D$*"$*& D#&
[D*H& JDEM/'%%H'+-("& '$(& ("7JDEM/'%%H'+-("&
%+.("&B"*H'$DE-%&"_*+'%*/&'$(&'EE&#+'%*-D$/&D#&I^&
B-$-B'& @'/& ("*"+B-$"(& ./-$,& \DE-$7I-D%'E*".&
+"',"$*^&1$&H"+"C&9<&m?&D#&%+.("&'E,'&"_*+'%*/&'$(&
H"_'$"C& %HED+D#D+BC& "*HME& '%"*'*"& '$(& 'b."D./&
#+'%*-D$/& @"+"& B-_"(& @-*H& #+"/HEM& J+"J'+"(&
\DE-$7I-D%'E*".& +"',"$*& XAA<& m?& D#& A<& *-B"/&
(-E.*"(Y& #+"/HEM& J+"J'+"(& '$(& '(("(& 5<& pE& D#&
/D(-.B& %'+[D$'*"& /DE.*-D$& *D& $".*+'E-]"& *H"&
/DE.*-D$^&LH"$C&*H"& 48& @"EE& JE'*"&X#.EEM&%DK"+"(&
@-*H& 'E.B-$-.B& #D-EY& @-*H& *H"& /DE.*-D$& @'/&
-$%.['*"(&'*& +DDB& *"BJ"+'*.+"&#D+&O<&B-$&'$(&
-*/& '[/D+['$%"& @'/& B"'/.+"(& ./-$,&
/J"%*+DJHD*DB"*"+&'*&*H"&@'K"E"$,*H&D#&58;$B&
[M&./-$,&@'*"+&'/&*H"&/'BJE"&[E'$T&XQ.$'*H-E'T'&
"*&'E^C&9<A4Y^&
O^9Y& LD*'E& \E'KD$D-(& %D$*"$*& XL\IY&
("*"+B-$'*-D$0& !"*"+B-$'*-D$& D#& *H"& *D*'E&
#E'KD$D-(&%D$*"$*&D#&[D*H&JDEM/'%%H'+-("&'$(&("7
JDEM/'%%H'+-("& %+.("& B"*H'$DE& "_*+'%*/& D#& I^&
B-$-B'& @"+"& ("*"+B-$"(& [M& ./-$,& *H"&
'E.B-$-.B&%HED+-("^&1$&H"+"C&%+.("&'E,'E&"_*+'%*/&
'$(& 'EE& *H"& D*H"+& #+'%*-D$/& D#& I^& B-$-B'& @"+"&
B-_"(&@-*H&'[/DE.*"&B"*H'$DE&'$(&A<<&m?&D#&*H"&
/'BJE"& @'/& B-_"(& @-*H& A<<m?& D#& 9g& GEIE3&
/DE.*-D$&-$&B"*H'$DE^&LH"$&*H"&48&@"EE&JE'*"&@-*H&
/'BJE"/& @"+"& #.EE& %DK"+"(& @-*H& '$& 'E.B-$-.B&
#D-E& '$(& -$%.['*"(&'*& +DDB& *"BJ"+'*.+"& #D+& A<&
B-$.*"/& '$(& *H"& '[/D+['$%"& @'/& B"'/.+"(& '*&
*H"& @'K"E"$,*H& D#& :A;$B& ./-$,&
/J"%*+DJHD*DB"*"+&XQ.$'*H-E'T'&"*&'E^C&9<A4Y^&
! !!!!!!!!!! !
!
72!
O^OY&LD*'E&GET'ED-(&%D$*"$*&XLGIY&("*"+B-$'*-D$0&
!"*"+B-$'*-D$& D#& *H"& *D*'E& 'ET'ED-(& %D$*"$*& D#&
[D*H& JDEM/'%%H'+-("& '$(& ("7JDEM/'%%H'+-("&
B"*H'$DE& #+'%*-D$/& D#& I^& B-$-B'& @"+"&
("*"+B-$"(& [M& ./-$,& !+',"$(D+##& +"',"$*^& A<&
B,lB?& 'E,'"& %+.("&B"*H'$DE& "_*+'%*/C& H"_'$"C&
%HED+D#D+BC&"*HME&'%"*'*"&'$(&'b."D./&#+'%*-D$/&
@"+"&(-E.*"(& @-*H& 4;g& "*H'$DE^& LH"$&A<<&mE& D#&
*H"& /'BJE"/& @"+"& B-_"(& @-*H& 9<<& m?& D#&
!+',"$(D+##& +"',"$*C& '$(& %"$*+-#.,"(& '*& *H"&
/J""(& D#& ;<<<& +JB& #D+& ;& B-$.*"/^& G#*"+&
%DBJE"*-$,& *H"& %"$*+-#.,'*-D$& J"+-D(C&
/.J"+$'*'$*& @'/& (-/%'+("(& '$(& *H"& +"B'-$-$,&
J"EE"*&-/&@'/H"(&@-*H& 4;g& "*H'$DE& '$(& *+"'*"(&
@-*H& 9<<& m?& D#& Ag& (-/D(-.B& /.E#-("& /DE.*-D$^&
LH"$&*H"&#D+B"(&J"EE"*&@'/&','-$&%"$*+-#.,"(&'*&
;<<<+JB&#D+&;&B-$.*"/^&G#*"+&*H"&%"$*+-#.,'*-D$C&
/.J"+$'*'$*& @'/& +"BDK"(& '$(& *H"& J"EE"*& @'/&
(-//DEK"(& -$& 9<<& m?&D#& %D$%^& F3hO& '$(& *DJ& .J&
@-*H& (-/*-EE"(& @'*"+^& \+DB& *H-/& /DE.*-D$C& A<<mE&
@'/&*'T"$&'$(&B-_"(&@-*H&;<<&m?&D#&Og&*H-D.+"'&
-$/-("& '& A;BE& "JJ"$(D+#& *.["& '$(& *H"&
'[/D+['$%"& @'/& B"'/.+"(& '*& '& @'K"E"$,*H& D#&
:8<&$B&./-$,&/J"%*+DJHD*DB"*"+^&
:Y&1$&K-*+D&'$*-D_-('$*&'//'M/&&
:^AY&!UUF&'//'M&X9C&97(-JH"$ME7A7J-%+MEHM(+']ME&
#+""&+'(-%'E&/%'K"$,-$,&'//'MY0&I^&B-$-B'&%+.("&
B"*H'$DE-%& "_*+'%*/& '$(& 'EE& *H"& #+'%*-D$/& @"+"&
*"/*"(& @-*H& /-_& /'BJE"& %D$%"$*+'*-D$/& +'$,-$,&
#+DB&5^6ApE&*D&A9;pE^&1$&H"+"C&:<&p,lB?&D#&!UUF&
@'/& B-_"(& @-*H& 9<<pE& D#& B"*H'$DE& *D& J+"J'+"&
#+"/H& !UUF& /DE.*-D$^& LH"$& *H"& ;<& pE& /'BJE"/&
X[D*H& JDEM/'%%H'+-("& '$(& ("7JDEM/'%%H'+-("& I^&
B-$-B'& "_*+'%*/Y& @"+"& B-_"(& @-*H& *H"& !UUF&
/DE.*-D$& '$(& E"*& #D+& A;& B-$.*"/& '*& +DDB&
*"BJ"+'*.+"& #D+& -$%.['*-D$^& LH"$& *H"&
'[/D+['$%"&@'/&B"'/.+"(&'*&;A5$B&@'K"E"$,*H&
'$(& %'E%.E'*"(& *H"& g& P)G& '$(& 1I;<& K'E."& #D+&
"K"+M&/'BJE"&'$(&*H"&J"+%"$*',"&-$H-[-*-D$&@'/&
%'E%.E'*"(&./-$,& *H"& "b.'*-D$& D#& „g& 1$H-[-*-D$s&
„XG& %D$*+DE& 7& G& /'BJE"YlG& %D$*+DE…& _A<<…&
XQ.$'*H-E'T'&"*&'E^C&9<A4Y^&&
&
:^9Y& hPGI& '//'M& Xh_M,"$& +'(-%'E& '[/D+['$%"&
%'J'%-*MY0& !"7JDEM/'%%H'+-("& '$(&
JDEM/'%%H'+-("&+-%H&I^&B-$-B'&%+.("&B"*H'$DE-%&
"_*+'%*/&'$(&'EE&*H"-+&#+'%*-D$/&@"+"&*"/*"(&@-*H&
/-_&/'BJE"&%D$%"$*+'*-D$/&+'$,-$,&#+DB&5^6ApE&*D&
A9;pE^&1$& H"+"C&A<pE&/'BJE"/&@"+"&'(("(&*D&*H"&
48@"EE&JE'*"&'$(&'(("(&:<&pE&D#&JHD/JH'*"&[.##"+&
XJF&5^:Y^& LD& -*C&A<<pE&D#& #E.D+"/%"-$& @'/& '(("(&
'$(& -$%.['*"(& '*& +DDB& *"BJ"+'*.+"& #D+& ;&
B-$.*"/^&LH"$C&;<&pE&D#&GGUF&/DE.*-D$&@'/&'(("(&
*D&-*&'$(&*H"&("%'M&D#&#E.D+"/%"$%"&@'/&/%'$$"(&
#D+& O;& B-$.*"/& '*& AB-$.*"& -$*"+K'E& '*& +DDB&
*"BJ"+'*.+"^& \-$'EEMC& *H"& '+"'& .$("+& *H"& %.+K"&
XGRIY& @'/& +"%D+("(& #D+& *H"& /'BJE"/&
XQ.$'*H-E'T'&"*&'E^C&9<A4Y^&&&&
¥ hPGI&K'E."& s&X3"*&GRI&/'BJE"&l& $"*& GRI&
L+DED_Y& •& XL+DED_& %D$%"$*+'*-D$l/'BJE"&
%D$%"$*+'*-D$Y&&
¥ 3"*& GRI& /'BJE"& s& XGRI& /'BJE"& e& GRI&
[E'$TY&&
¥ 3"*&GRI&L+DED_&s&XGRI&L+DED_&e&GRI&[E'$TY&&&
:^OY& \PGU& '//'M& X\E.D+"/%"$%"& +"%DK"+M& '#*"+&
JHD*D[E"'%H-$,Y0& U+"J'+"(& ("7JDEM/'%%H'+-("&
'$(&JDEM/'%%H'+-("7+-%H&I^&B-$-B'&"_*+'%*/&@"+"&
/.[S"%*"(& *D& ("*"+B-$"& #"++-%& +"(.%-$,&
'$*-D_-('$*& JD@"+& X\PGUY^& 1$& H"+"C& A;<& pE& D#&
\PGU&+"',"$*&@'/&'(("(&*D&*H"&48@"EE&JE'*"&'$(&
O<&pE&D#&'%"*'*"&[.##"+&@'/&'(("(&*D&-*^&LH"$C&9<pE&
D#&/'BJE"C&L+DED_& '/& *H"& /*'$('+(& '$(& @'*"+& '/&
*H"&[E'$T&@'/&'(("(&*D&-*&'$(&-$%.['*"(&'*&+DDB&
*"BJ"+'*.+"& #D+& 6B-$.*"/^& \-$'EEMC& *H"&
'[/D+['$%"& @'/& +"%D+("(& '*& 8<<$B&
XQ.$'*H-E'T'&"*&'E^C&9<A4Y^&
&
:^OY& G2L)+& '//'M& XX9C9`7G]-$D7[-/& XO7
"*HME["$]*H-']DE-$"787/.E#D$-%& '%-(Y& +'(-%'E&
/%'K"$,-$,&'//'M0&LH"&G2L)+&%'*-D$&+'(-%'E&@'/&
,"$"+'*"(& [M& *H"& +"'%*-D$& ["*@""$& A<B,& D#&
G2L)& -$& 9^;B=& JD*'//-.B& J"+/.E#'*"& /DE.*-D$&
X9^;B?Y& '*& O5kI& #D+& A8& H& -$& *H"& ('+T^& GE,'"&
#+'%*-D$/& '$(& /.[7#+'%*-D$/& @"+"& *"/*"(& '*& *H"&
'//'M& %D$%"$*+'*-D$& +'$,"& D#& A7;& B,lBE^& LH"&
+"'%*-D$&KDE.B"&D#&9<<&p?&%D$*'-$-$,&:<& p=& D#&
! !!!!!!!!!! !
!
73!
G2L)+&+'(-%'E&'$(&;<&p?&D#&"_*+'%*l#+'%*-D$&@'/&
-$%.['*"(& '*& 9;& r& 9kI& #D+& A<& B-$.*"/^& LH"&
'[/D+['$%"& @'/& +"%D+("(& '*& '& @'K"E"$,*H& D#&
5O:$B^& L+DED_& @'/& ./"(& '/& *H"& /*'$('+(&
'$*-D_-('$*C& '$(& +"/.E*/& @"+"& "_J+"//"(& '/& B,&
L+DED_& "b.-K'E"$*& #D+& A& ,& D#& *H"& (+M& @"-,H*& D#&
"_*+'%*l#+'%*-D$^& LH"& %'J'%-*M& *D& /%'K"$,"& *H"&
G2L)n& %'*-D$& [M& ;<g& X1I;<Y& @'/& %'E%.E'*"(&
#+DB& *H"& (D/"7+"/JD$/"& %.+K"/& [M& E-$"'+&
+",+"//-D$&'$(& J"+%"$*',"&%'E%.E'*"(& ./-$,& *H"&
#DEED@-$,&"b.'*-D$&XQ.$'*H-E'T'&"*&'E^C&9<A4Y^&&
¥ g& 1$H-[-*-D$s& „XG& %D$*+DE7G& /'BJE"Yl& G&
%D$*+DE…&u&A<<&
¥ G& /'BJE"& s& '[/D+['$%"& D#& *H"&
"_*+'%*l#+'%*-D$&
¥ G&%D$*+DE& s& '[/D+['$%"&D#& *H"&'//'M&./-$,&
*H"&[.##"+&-$/*"'(&D#&"_*+'%*l#+'%*-D$&
3.%%Results%and%Discussions%
G/& D.+& +"/.E*/& /HD@C& '& H-,H& E"K"E& D#& LUI& @'/&
D[/"+K"(& -$& %+.("& B"*H'$DE& "_*+'%*& D#& ("7
JDEM/'%%H'+-("&X946^<5&r&<^<<O&B,&QG>l,Y&'$(&
'b."D./& #+'%*-D$& XA:A^9& r& <^<<9& B,& QG>l,Y&D#&
JDEM/'%%H'+-("&"_*+'%*^&&LH"&H-,H"/*&E"K"E&D#&L\I&
@'/& D[/"+K"(& -$& [D*H&'b."D./& #+'%*-D$/& D#& ("7
JDEM/'%%H'+-("& X;4:^9O& r& <^<<A& B,& i>l,Y& '$(&
JDEM/'%%H'+-("& XAAO^:8& r& <^<A6& B,& i>l,Y&
"_*+'%*/& D#& I^& B-$-B'^& IHED+D#D+B& #+'%*-D$/&
"_H-[-*"(&*H"&H-,H"/*&LGI&D#&[D*H&JDEM/'%%H'+-("&
X9^9<& r& <^:;& B,& U>l,Y& '$(& ("7JDEM/'%%H'+-("&
X9^54&r&<^OA&B,&U>l,Y&"_*+'%*/&D#&I^&B-$-B'^&&
&
1$&*"+B/& D#& '$*-D_-('$*&'%*-K-*M&("*"+B-$'*-D$/C&
@"&@"+"&-$K"/*-,'*"(&*H'*C&"*HME&'%"*'*"&#+'%*-D$&
D#&[D*H&JDEM/'%%H'+-("&X1I;<0<^85&r&<^<A&B,lBEY&
'$(& ("7JDEM/'%%H'+-("& X1I;<0<^;4& r& <^<A;&
B,lBEY&B"*H'$DE&&
&
>_*+'%*/& D#& I^& B-$-B'& "_H-[-*"(& '& H-,H& E"K"E& D#&
'$*-D_-('$*&'%*-K-*M&-$&!UUF&'//'M^&)-B-E'+EMC&*H"&
H-,H"/*& E"K"E& D#& D_M,"$& +'(-%'E& '[/D+['$%"&
%'J'%-*M& @'/& D[/"+K"(& -$& *H"& "*HME& '%"*'*"&
#+'%*-D$&D#&[D*H&("7JDEM/'%%H'+-("&XA4^5O&r&;^OA&
B,&L>l,Y&'$(&JDEM/'%%H'+-("&%+.("&"_*+'%*/&D#&I^&
B-$-B'& XA8^99& r& :^OA& B,& L>l,Y^& \E.D+"/%"$%"&
+"%DK"+M&'#*"+&
&
&JHD*D[E"'%H-$,& X\PGUY& '//'M& /HD@/& JD*"$*&
'$*-D_-('$*& '%*-K-*M& -$& "*HME& '%"*'*"& #+'%*-D$& D#&
[D*H&JDEM/'%%H'+-("&XA4^9O&r&A^46&B,&L>l,Y&'$(&
("7JDEM/'%%H'+-("& X9<^O:& r& A^59& B,& L>l,Y&
"_*+'%*/&D#&I^&B-$-B'^&F-,H&G2L)+#@'/&D[/"+K"(&
-$&"*HME&'%"*'*"&#+'%*-D$/&D#&[D*H&JDEM/'%%H'+-("&
X1I;<0<^<6& r& <^<<9& B,lBEY& '$(& ("7
JDEM/'%%H'+-("& X1I;<0<^<8& r& <^<<AB,lBEY&
/"#W-8.
:$",46&'.
[9N.
<#2.`KRa2@.
[:N.
<#2.DRa2@.
[KN.
<#2.9Ra2@.
W&-3!",,1"$6)8.$6,1.
#841"'&-.8]4$",4.
N$*)8.
A8]"'8.
N1-&$&O&$#.
R413-Q",84"48.
Kb*8&*!.
GC+=cC+CFI.
BB.c.C+CFB.
EG.c.C+CCB..
FFI+B.c.C+CFB..
FIF+B.c.C+CCB.
QBF+F>.c.C+CCI.
QBG+GI.c.C+CCB.
HG+GI.c.C+CC>.
=C+EG.c.C+CBG.
FFE+I5.c.C+CFG.
........F+>BcC+CB.
........F+FBcC+C5.
........B+BCcC+I>.
........F+FBcC+IH.
........C+ICc.C+CE.
Z8W&-3!",,1"$6)8.
#841"'&-.8]4$",4.
N$*)8.
A8]"'8.
N1-&$&O&$#.
R413-Q",84"48.
Kb*8&*!.
B=G+CH.c.C+CCE..
BF+F>.c.C+CCB.
F5E+I5.c.C+CCE...
BB+>.c.C+CC5.
B5H+EC.c.C+CC>...............
>+H5.cC+CCF..
Q>F+=B.c.C+CCF.
Q5H+EC.c.C+CCF..
Q>F+=B.c.C+CCF..
>=I+BE.c.C+CCF.
F+HEcC+>>.
F+E5cC+5=.
B+H=cC+EF.
F+IEcC+IH.
C+>Fc.C+BC..................................................
Table 1. In vitro phytochemical assays (TPC, TFC, TAC) and their results for De-polysaccharideand polysaccharide
crude methanol extracts of C. minima and fractions
! !!!!!!!!!! !
!
74!
"_*+'%*/^&2'/"(&D$&*H"&+"/.E*/&-*&-/&#D.$("(&*H'*C&
H"_'$"&#+'%*-D$&D#& [D*H&JDEM/'%%H'+-("& '$(& ("7
JDEM/'%%H'+-("& I^B-$-B'& "_*+'%*/& '+"& *H"& E"'/*&
'%*-K"&&
&
&
#+'%*-D$&#D+& 'EE& '$*-D_-('$*&'//'M/&'$(&-*& %'$& ["&
%D$%E.("(&*H'*&*H"&"*HME&'%"*'*"&#+'%*-D$/&D#&[D*H&
JDEM/'%%H'+-("&'$(& ("7& JDEM/'%%H'+-("& "_*+'%*/&
@"+"& #D.$(& '/& -("'E& #+'%*-D$/& @-*H& JD*"$*-'E&
'$*-D_-('$*& '%*-K-*-"/&'$(& #.+*H"+C& "*HME7'%"*'*"&
#+'%*-D$& D#& ("7JDEM/'%%H'+-("& %+.("& B"*H'$DE&
"_*+'%*& "_H-[-*"(& *H"& H-,H"/*& '$*-D_-('$*&
%'J'%-*M&@H-%H&E"'(/&*D&(+.,&("K"EDJB"$*^&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&&
&
&
0.31
5.57
0.97 0.08 0.36 0.01
0.25
4.71
0.12 0.06 0.28 0.01
0
2
4
6
Crude Hexane Chloroform Ethyl-acetate Aqueous Trolox
% Radical scavenging activity
Assay concentration (mg/ml)
B
Polysaccharide extract De-polysaccharide extract
\-,.+"&A&e&Q+'JH/&#D+&(A)&!UUF&'$(&(B)%G2L)n&+'(-%'E&/%'K"$,-$,&'%*-K-*M&D#&JDEM/'%%H'+-("&
%+.("&B"*H'$DE&"_*+'%*C&("7JDEM/'%%H'+-("&%+.("&B"*H'$DE&"_*+'%*&'$(&*H"-+&#+'%*-D$/&
! !!!!!!!!!! !
!
75!
4.22
7.56
13.95
19.23
2.21
5.86
8.57
13.95
20.34
18.04
0
5
10
15
20
25
Crude Hexane Chloroform Ethyl-acetate Aqueous
FRAP
Assay concentration (mg TE/g)
D
Polysaccharide extract De-polysaccharide extract
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
5.12 3.02
12.23
16.22 14.25
6.65 4.08
17.72 19.73 18.04
0
5
10
15
20
25
Crude Hexane Chloroform Ethyl-acetate Aqueous
Oxygen radical absorance
capacity
Assay concentration (mg TE/g)
C
Polysaccharide extract De-polysaccharide extract
\-,.+"&9&e&Q+'JH/&#D+&(C)&hPGI&'$(&(D)%\PGU&'%*-K-*M&D#&JDEM/'%%H'+-("&%+.("&B"*H'$DE&"_*+'%*C&
("7JDEM/'%%H'+-("&%+.("&B"*H'$DE&"_*+'%*&'$(&*H"-+&#+'%*-D$/&
.
:$",46&'.
Z99A.
UN>C.<#2a#-@.
dLKN.
<#2.[Ra2@.
:LK9.
<#2.[Ra2@.
KV[/"#
UN>C<#2a#-@.
N.#6'6#".
W&-3!",,1"$6)8.
O$",46&'.
N$*)8.
A8]"'8.
N1-&$&O&$#.
R413-Q
",84"48.
Kb*8&*!.
[$&-&].
.......C+>G.c.C+CF.
B+>5.c.C+CF.
C+G5.c.C+CCB.
C+5H.c.C+CF..
C+GE.c.C+CCF..
C+CF.c.C+CCC.
>+FBcC+B=..
E+CBcF+E=.
FB+BEcB+I>..
F5+BBcI+EF..
FI+B>cF+B=..
Q..........................................................................................................................
.........I+BBcF+GF.
..........H+>5cF+F.
........FE+=>cF+BE.
........F=+BEcF+=G.
.........B+BFcC+CB.
..................Q..................
.........C+EFcC+CCB.
..........>+>HcC+CB.
..........C+=HcC+CCF.
..........C+CGcC+CCB.
..........C+E5cC+CC>.
..........C+CFcC+CC.
N.#6'6#".
)8W&-3!",,1"$6)8.
O$",46&'.
N$*)8.
A8]"'8.
N1-&$&O&$#.
R413-Q
",84"48.
Kb*8&*!.
[$&-&].
.........C+IG.c.C+CF..
........F+GG.c.C+CB..
.......C+H>.c.C+CCB.
.......C+>=.c.C+CF>.
.......C+H=.c.C+CC5.
.......C+CF.c.C+CCC...........................................................
5+5>cC+IB.
I+CGcF+II.
FH+HBcB+=B.
F=+HEc>+EF.
FG+CIcF+5E.
Q.
>+G5cF+F=.
G+>HcF+FE.
FE+=>cF+>>.
BC+EIcF+HB..
I+C5cC+B=.
Q................................................
C+B>cC+CCF.
I+HFcC+EF.
C+FBcC+CC=.
C+C5cC+CCF.
C+BGcC+CCE.
C+CCGcC+CC.
!
Table 2 - In vitro antioxidant assay (DPPH, ORAC, FRAP) results for De-polysaccharide and polysaccharide
Crude methanol extracts of C. minima and fractions
! !!!!!!!!!! !
!
76!
&
References%
&
G[-+'B-C& P^Q^& '$(& VD@/'EM'C& )^& X9<A8Y&
vi.'$*-#-%'*-D$&'$(&ID++"E'*-D$&)*.(M&D$&!"+-K"(&
UH"$DE/& '$(& G$*-D_-('$*& G%*-K-*M& D#& )"'@""(/&
#+DB& Q.E#& D#& ='$$'+& i.'$*-#-%'*-D$& '$(&
ID++"E'*-D$& )*.(M& D$& !"+-K"(& UH"$DE/& '$(&
G$*-D_-('$*& G%*-K-*M& D#& )"'@""(/& #+DB& Q.E#& D#&
='$$'+aC& ND.+$'E& D#& F"+[/C& )J-%"/& y& ="(-%-$'E&
UE'$*/C& <<X<<YC& JJ^& Ae4^&
(D-0A<^A<6<lA<:48:5;^9<A8^A9:<AO9^&
‹'T-+&G+-%'C&Ž^&"*&'E^&X9<A5Y&vG&/*.(M&D$& *H"& +-%H&
%DBJD.$(/&'$(&JD*"$*-'E&&&&["$"#-*/&D#&'E,'"0&G&
+"K-"@aC&LH"& UH'+B'& 1$$DK'*-D$& ND.+$'EC&8XA9YC&
JJ^& :9e;A^& GK'-E'[E"& '*0&
@@@^*H"JH'+B'SD.+$'E^%DB^&
!D[+"*/DKC& )^& "*& 'E^& X9<A8Y& v)%+""$-$,& #D+& '$*-7
%'$%"+& %DBJD.$(/& -$& B'+-$"& D+,'$-/B/& -$&
hB'$aC&).E*'$&i'[DD/&R$-K"+/-*M&="(-%'E&
ND.+$'EC& A8X9YC& JJ^& "A86e"A5:^&
(D-0A<^A694;l/b.BS^9<A8^A8^<9^<<8^&
!M/HEDKDMC&)^G^&'$(&FD$"%T"+C&\^&X9<A;Y&v='+-$"&
%DBJD.$(/& '$(& %'$%"+0& ZH"+"& (D& @"& /*'$(•aC&
='+-$"& !+.,/C& AOX4YC& JJ^& ;8;5e;88;^&
(D-0A<^OO4<lB(AO<4;8;5^&
\"+$'$(DC& 1^U^)^& X9<A5Y& 2-D'%*-K"& $'*.+'E&
J+D(.%*/&#+DB&B'+-$"&'E,'"&'$(&/D#*&%D+'E/^&
Q'$"/'$C&U^C&V.B'+C&I^)^&'$(&2H'/T'+C&3^&X9<<6Y&
vG$*-D_-('$*&J+DJ"+*-"/&D#&B"*H'$DE&"_*+'%*&'$(&
-*/& /DEK"$*& #+'%*-D$/& D[*'-$"(& #+DB& /"E"%*"(&
1$(-'$& +"(& /"'@""(/aC& 44C& JJ^& 95A5e959O^&
(D-0A<^A<A8lS^[-D+*"%H^9<<5^<5^<<;^&
Q.$'*H-E'T'C& L^?^& "*& 'E^& X9<A4Y& v1$& 7& W-*+D&
G$*-D_-('$*& C& FMJD,EM%"B-%& G%*-K-*M& C& '$(&
1("$*-#-%'*-D$&D#&2-D'%*-K"&IDBJD.$(/&-$&UH"$DE&
7& P-%H& >_*+'%*& #+DB& *H"& ='+-$"& P"(& GE,'"&
Q+'%-E'+-'& "(.E-/& X& QB"E-$& Y& )-EK'aC& JJ^& AeA8^&
(D-0A<^OO4<lBDE"%.E"/9:9<O5<6^&
Q.*-Œ++"]7PD(+‡,."]C& G^Q^& "*& 'E^& X9<A6Y&
vG$*-%'$%"+& '%*-K-*M& D#& /"'@""(/aC& !+.,&
!-/%DK"+M& LD('MC& 9OX9YC& JJ^& :O:e::5^&
(D-0A<^A<A8lS^(+.(-/^9<A5^A<^<A4^&
LD++"/C& U^& "*& 'E^& X9<A4Y& vP"K-"@& '+*-%E"& G&
%DBJ+"H"$/-K"& +"K-"@& D#& *+'(-*-D$'E& ./"/& C&
[-D'%*-K-*M&JD*"$*-'E& C& '$(&%H"B-%'E&(-K"+/-*M&D#&
*H"&,"$./&Q+'%-E'+-'&X&Q+'%-E'+-'E"/&C&PHD(DJHM*'&
YaC&GE,'E&P"/"'+%HC&O5X!"%"B["+&9<A6YC&JJ^&966e
O<8^&(D-0A<^A<A8lS^'E,'E^9<A6^A9^<<4^&
Z'$7?DMC& I^& '$(& )-"@7=D-C& U^& X9<A8Y& v='+-$"&
'E,'"& '/& '& JD*"$*-'E& /D.+%"& #D+& '$*-7D["/-*M&
',"$*/aC& ='+-$"& !+.,/C& A:XA9YC& JJ^& AeA4^&
(D-0A<^OO4<lB(A:A9<999^&
K'$&Z""E("$C&Q^&"*&'E^&X9<A4Y&v\.%D-('$&/*+.%*.+"&
'$(& '%*-K-*M& -$& +"E'*-D$& *D& '$*-7%'$%"+&
B"%H'$-/B/aC& ='+-$"& !+.,/C& A5XAY^&
(D-0A<^OO4<lB(A5<A<<O9^&
&
Abbreviations%%
!UUF79C97(-JH"$ME7A7J-%+MEHM(+']MEC& LUI7LD*'E&
JDEMJH"$DE-%& %D$*"$*C& L\I7LD*'E& #E'KD$D-(&
%D$*"$*C& LGI7LD*'E& 'ET'ED-(& %D$*"$*C& \PGU7
\ED.+"/%"$/"& +"%DK"+M& '#*"+& JHD*D[E"'%H-$,C&
hPGI7h_M,"$& +'(-%'E& '[/D+['$%"& %'J'%-*MC& I^&
B-$-B'7& IH$DD/JD+'& B-$-B'C& G2L)+# 7& 9C9`7
G]-$D72-/XO7& >*HME["$]D*H-']DE-$"787).EJHD$-%&
G%-(YC&QG>&7Q'EE-%&G%-(&>b.-K'E"$*C&Ph)7P"'%*-K"&
h_M,"$&)J"%-"/C&L>7L+DED_&>b.-K'E"$*^&
&
&
&
Acknowledgment%
LH-/& +"/"'+%H& @'/& '& J'+*& D#& *H"& J+DS"%*& *-*E"(&
vv>K'E.'*-D$&D#&'$*-7J+DE-#"+'*-K"&'%*-K-*-"/&D#&*H"&
-/DE'*"(&[-D'%*-K"& %D$/*-*."$*/&#+DB&)+-& ?'$T'$&
B'+-$"& 'E,'"& IH$DD/JD+'& B-$-B'aaC& #.$("(& [M&
*H"& V!R7IGP>C& .$("+& ,+'$*0&
V!RlPQl9<9AlIGP>l<<A^&
%
&
! !!!!!!!!!! !
!
77!
Author%Biography%
=/^& F-+.$-& )& V.B'+'/-$,H"& -/& '& #+"/H& ,+'(.'*"&
@-*H& '& #D.+7M"'+& 22)L& !",+""& -$& 2-D/M/*"B/&
L"%H$DED,MC& /J"%-'E-]-$,& -$& 2-DJ+D%"//&
L"%H$DED,M& #+DB& P'S'+'*'& R$-K"+/-*M& D#& )+-&
?'$T'^& )H"& HDE(/& '$& FD$D+/& !",+""& @-*H& '&
)"%D$(&IE'//& RJJ"+& !-K-/-D$^& \D+& H"+& #-$'E& M"'+&
+"/"'+%HC& /H"& SD-$"(& @-*H& V!R7IGP>& @-*H& '&
P"/"'+%H& G//-/*'$*/H-J& #+DB& 9<9A^& F"+&
.$("+,+'(.'*"&J+DS"%*&@'/&['/"(&D$&c>K'E.'*-D$&
D#& '$*-7J+DE-#"+'*-K"& '%*-K-*-"/& D#& *H"& -/DE'*"(&
[-D'%*-K"& %D$/*-*."$*/& #+DB& )+-& ?'$T'$& B'+-$"&
'E,'&IH$DD/JD+'&B-$-B'd&
%
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Obesity and diabetes are major metabolic disorders which are prevalent worldwide. Algae has played an important role in managing these disorders. In this study, Gracilaria edulis, a marine red algae, was investigated for antioxidant and hypoglycemic potential using in vitro models. De-polysaccharide methanol extract of G. edulis was sequentially partitioned with hexane, chloroform, ethyl acetate, and antioxidants, and hypoglycemic potentials were evaluated using multiple methods. High antioxidant potential was observed in the ethyl acetate fraction in terms of ferric reducing antioxidant power, iron chelating, and DPPH and ABTS radical scavenging activities, while the crude methanol extract exhibited potent oxygen radical-absorbance capacity. Potent α-amylase inhibitory activity was observed in the ethyl acetate fraction, while the ethyl acetate fraction was effective against α-glucosidase inhibition. Glucose diffusion was inhibited by the ethyl acetate fraction at 180 min, and the highest antiglycation activity was observed in both chloroform and ethyl acetate fractions. Additionally, gas chromatography-mass spectrometry analysis of the ethyl acetate fraction revealed the presence of several potent anti-diabetic compounds. In conclusion, G. edulis exhibited promising antidiabetic potential via multiple mechanisms. The ethyl acetate fraction exhibited the strongest hypoglycemic and antiglycation potential among the four fractions, and hence the isolation of active compounds is required to develop leads for new drugs to treat diabetes.
Article
Full-text available
Objectives: Marine organisms are a rich source of bioactive molecules with potential applications in medicine, biotechnology and industry; however, few bioactive compounds have been isolated from organisms inhabiting the Arabian Gulf and the Gulf of Oman. This study aimed to isolate and screen the anti-cancer activity of compounds and extracts from 40 natural products of marine organisms collected from the Gulf of Oman. Methods: This study was carried out between January 2012 and December 2014 at the Sultan Qaboos University, Muscat, Oman. Fungi, bacteria, sponges, algae, soft corals, tunicates, bryozoans, mangrove tree samples and sea cucumbers were collected from seawater at Marina Bandar Al-Rowdha and Bandar Al-Khayran in Oman. Bacteria and fungi were isolated using a marine broth and organisms were extracted with methanol and ethyl acetate. Compounds were identified from spectroscopic data. The anti-cancer activity of the compounds and extracts was tested in a Michigan Cancer Foundation (MCF)-7 cell line breast adenocarcinoma model. Results: Eight pure compounds and 32 extracts were investigated. Of these, 22.5% showed strong or medium anti-cancer activity, with malformin A, kuanoniamine D, hymenialdisine and gallic acid showing the greatest activity, as well as the soft coral Sarcophyton sp. extract. Treatment of MCF-7 cells at different concentrations of Sarcophyton sp. extracts indicated the induction of concentration-dependent cell death. Ultrastructural analysis highlighted the presence of nuclear fragmentation, membrane protrusion, blebbing and chromatic segregation at the nuclear membrane, which are typical characteristics of cell death by apoptosis induction. Conclusion: Some Omani marine organisms showed high anti-cancer potential. The efficacy, specificity and molecular mechanisms of anti-cancer compounds from Omani marine organisms on various cancer models should be investigated in future in vitro and in vivo studies.
Article
Full-text available
In Western countries, cancer is among the most frequent causes of death. Despite striking advances in cancer therapy, there is still an urgent need for new drugs in oncology. Current development favors so called “targeted agents” or drugs that target the immune system, i.e., therapeutic antibodies that enhance or facilitate an immune response against tumor cells (also referred to as “checkpoint inhibitors”). However, until recently, roughly 60% of drugs used in hematology and oncology were originally derived from natural sources, and one third of the top-selling agents are either natural agents or derivatives [1]. There is justified hope for the discovery and development of new anticancer agents from the marine environment. Historically, this habitat has proven to be a rich source of potent natural compounds such as alkaloids, steroids, terpenes, macrolides, peptides, and polyketides, among others. Interestingly, marine agents and cancer treatment have had a special relationship from the beginning. One of the first marine-derived compounds, discovered in 1945 that was later developed into a clinically used drug, was spongothymidine [2–4], which was the lead compound for the discovery of cytarabine [5]. Until today, cytarabine remains one of the most widely used agents in the treatment of acute myeloid leukemia and relapsed aggressive lymphomas. [...]
Article
Full-text available
In vitro antioxidant activities of three selected Indian red seaweeds - viz., Euchema kappaphycus, Gracilaria edulis and Acanthophora spicifera were evaluated. Total phenolic content and reducing power of crude methanol extract were determined. The antioxidant activities of total methanol extract and five different solvent fractions (viz., petroleum ether (PE), ethyl acetate (EA), dichloromethane (DCM), butanol (BuOH) and aqueous) were also evaluated. EA fraction of A. spicifera exhibited higher total antioxidant activity (32.01 mg ascorbic acid equivalent/g extract) among all the fractions. Higher phenolic content (16.26 mg gallic acid equivalent/g extract) was noticed in PE fraction of G. edulis. Reducing power of crude methanol extract increased with increasing concentration of the extract. Reducing power and hydroxyl radical scavenging activity of E. kappaphycus were higher compared to standard antioxidant (alpha-tocopherol). The total phenol content of all the seaweeds was significantly different (P<0.05). In vitro antioxidant activities of methanol extracts of all the three seaweeds exhibited dose dependency; and increased with increasing concentration of the extract.
Article
Selected seaweeds (Acanthophora spicifera, Gracilaria edulis, Padina gymnospora, Ulva fasciata, and Enteromorpha flexuosa) from the Gulf of Mannar coast, India, were analyzed for their antioxidant properties. Derived phenols in the methanolic extracts of these seaweeds were quantified and their scavenging activity against 1,1-diphenyl-2-picrylhydrazyl (DPPH) and nitric oxide were examined. Total phenol content was the highest in U. fasciata (23 mg TAE.g–1) and the lowest in A. spicifera (8.8 mg TAE.g–1). Caffeic acid ranged from 0.02 to 1.30 mg.100 g–1 and gallic acid ranged from 0.02 to 1.2 mg.100 g–1. Other derived phenols, coumeric acid, apigenin, chlorogenic acid, 3,4-dihydroxy benzoic acid, and qucercetin, were found in all species. U. fasciata showed the highest efficiency (11 µg.mL–1) against DPPH activity, while E. flexuosa (42 µg.mL–1) had the lowest low activity. G. edulis (36.3%) proved more potent in nitric oxide scavenging activity than any other species, and the lowest activity was noted in E. flexuosa (12.2%). There was a positive correlation between chlorogenic and gallic acids and radical scavenging activity.
Bioactive natural products from marine algae and soft corals
  • I P S Fernando
Fernando, I.P.S. (2017) Bioactive natural products from marine algae and soft corals.
algae as a potential source for anti-obesity agents9
  • P Torres
Torres, P. et al. (2019) 8Review article A comprehensive review of traditional uses, bioactivity potential, and chemical diversity of the genus Gracilaria ( Gracilariales, Rhodophyta )9, Algal Research, 37(December 2018), pp. 2883 306. doi:10.1016/j.algal.2018.12.009. Wan-Loy, C. and Siew-Moi, P. (2016) 8Marine algae as a potential source for anti-obesity agents9, Marine Drugs, 14(12), pp. 1319. doi:10.3390/md14120222. van Weelden, G. et al. (2019) 8Fucoidan structure and activity in relation to anti-cancer mechanisms9, Marine Drugs, 17(1). doi:10.3390/md17010032.